PROTECTIVE EFFECT OF AN SGLT2 INHIBITOR ON ER STRESS THROUGH REDUCTION OF ECTOPIC LIPID DEPOSITION IN RENAL TUBULES IN OBESE MICE

被引：0
|
作者：
Takata, Tomoaki [1 ]
Hosokawa, Kohshiro [1 ]
Sugihara, Takaaki [1 ]
Matono, Tomomitsu [1 ]
Koda, Masahiko [1 ]
Kanda, Tsutomu [1 ]
Ogawa, Masaya [1 ]
Ida, Ayami [1 ]
Mae, Yukari [1 ]
Yamamoto, Marie [1 ]
Iyama, Takuji [1 ]
Fukuda, Satoko [1 ]
Isomoto, Hajime [1 ]
机构：
[1] Tottori Univ, Fac Med, Div Med & Clin Sci, Yonago, Tottori, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0933
引用
收藏
页码：1260 / 1260
页数：1
相关论文
共 50 条
  • [21] The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice
    Day, Emily A.
    Ford, Rebecca J.
    Lu, Jessie H.
    Lu, Rachel
    Lundenberg, Lucie
    Desjardins, Eric M.
    Green, Alex E.
    Lally, James S., V
    Schertzer, Jonathan D.
    Steinberg, Gregory R.
    BIOCHEMICAL JOURNAL, 2020, 477 (12) : 2347 - 2361
  • [22] SGLT2 INHIBITOR PROTECTED RENAL PROXIMAL TUBULES FROM GLUCOSE-INDUCED APOPTOSIS VIA BCL-2-CASPASE PATHWAY
    Lee, Wen-Chin
    Chau, You-Ying
    Chen, Chiu-Hua
    Chen, Jin-Bor
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [23] SGLT2 inhibitor improves kidney function and morphology by regulating renal metabolism in mice with diabetic kidney disease
    Yang, Chunru
    Xiao, Cheng
    Zhai, Xiaojun
    Liu, Jieying
    Yu, Miao
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (02)
  • [24] FAILURE TO CONFIRM AN SGLT2 INHIBITOR-INDUCED HEMATOPOIETIC EFFECT IN NONDIABETIC RATS WITH RENAL ANAEMIA
    Nishiyama, Akira
    Nakano, Daisuke
    Konishi, Yoshio
    Morikawa, Takashi
    Yamazaki, Daisuke
    NEPHROLOGY, 2020, 25 : 37 - 37
  • [25] INVESTIGATION OF THE SUPPRESSIVE EFFECTS OF AN SGLT2 INHIBITOR ON GLOMERULAR HYPERFILTRATION AND OXIDATIVE STRESS IN MICE WITH DIABETIC KIDNEY DISEASE
    Kidokoro, Kengo
    Kondo, Megumi
    Satoh, Minoru
    Sasaki, Tamaki
    Kashihara, Naoki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [26] Comparison of the effects of insulin and SGLT2 inhibitor on the Renal Renin-Angiotensin system in type 1 diabetes mice
    Miyata, Kana N.
    Zhao, Shuiling
    Wu, Chin-Han
    Lo, Chao-Sheng
    Ghosh, Anindya
    Chenier, Isabelle
    Filep, Janos G.
    Ingelfinger, Julie R.
    Zhang, Shao-Ling
    Chan, John S. D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [27] SGLT1/2 expression in the heart of transplanted patients is associated with inflammatory induction of oxidative stress: potential protective effect of SGLT2 inhibitors
    Gong, D. S.
    Mroueh, A.
    Matsushita, K.
    Fakih, W.
    Auger, C.
    Oak, M. H.
    Pieper, M. P.
    Morel, O.
    Epailly, E.
    Schini-Kerth, V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 3007 - 3007
  • [28] Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes Mellitus
    Ikeda, Sachiya
    Takano, Yasuki
    Schwab, Dietmar
    Portron, Agnes
    Kasahara-Ito, Nahoko
    Saito, Tomohisa
    Iida, Satofumi
    DRUG RESEARCH, 2019, 69 (06) : 314 - 322
  • [29] A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin
    Theodoros Eleftheriadis
    Georgios Pissas
    Konstantina Tsogka
    Evdokia Nikolaou
    Vassilios Liakopoulos
    Ioannis Stefanidis
    International Urology and Nephrology, 2020, 52 : 1179 - 1189
  • [30] A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin
    Eleftheriadis, Theodoros
    Pissas, Georgios
    Tsogka, Konstantina
    Nikolaou, Evdokia
    Liakopoulos, Vassilios
    Stefanidis, Ioannis
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (06) : 1179 - 1189
12345